Integrace

Integrace is a specialty pharmaceutical company based in India that focuses on the gynaecology and orthopaedics therapeutic segments. Established in 2018 by the private equity firm True North through the acquisition of Glenmark Pharmaceuticals' domestic orthopaedic and gynaecology brands, the company quickly became a market leader in women's and bone health. Integrace further expanded its portfolio by acquiring branded formulations from Maneesh Pharmaceuticals before being acquired itself by Eris Lifesciences in 2022. The company's portfolio includes market-leading brands such as Dubagest and Gestofit, which are widely prescribed for pregnancy support and hormonal balance. Today, as a subsidiary of Eris Lifesciences, Integrace continues to operate as a commercial-stage powerhouse in the Indian domestic formulations market, focusing on chronic and sub-chronic care.